| Pharmaceutical active ingredients: |
| Cinnarizine |
| Available forms, composition and doses of Cinergil Forte: |
| Tablets; Oral; Cinnarizine 75 mg |
| Cinergil Forte medical category: |
| Human:Antivertigo drugsPeripheral vasodilators and cerebral activators |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N07CA02 - Cinnarizine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Labomed Instituto Farmaceutico |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Cardicon | Nifedipine | Labomed Instituto Farmaceutico |
| Cardicon Osmos | Nifedipine | Labomed Instituto Farmaceutico |
| Cardicon Retard | Nifedipine | Labomed Instituto Farmaceutico |
| Cinactiv | Erythromycin; Zinc (Zinc Acetate Dihydrate) | Labomed Instituto Farmaceutico |
| Cinergil | Cinnarizine | Labomed Instituto Farmaceutico |
| Diadicon | Bromhexine Hydrochloride; Clofedanol Hydrochloride | Labomed Instituto Farmaceutico |
| Diadicon Compuesto | Bromhexine Hydrochloride; Clofedanol Hydrochloride | Labomed Instituto Farmaceutico |
| Diadicon Pediatrico | Bromhexine Hydrochloride; Clofedanol Hydrochloride | Labomed Instituto Farmaceutico |
| Eciprax | Escitalopram Oxalate | Labomed Instituto Farmaceutico |
| Ergobelan | Belladonna; Ergotamine Tartrate; Phenobarbital | Labomed Instituto Farmaceutico |